The CERAD neuropsychologic battery total score and the progression of Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 24, Issue 2, 2010, Pages 138-142

  Rossetti, Heidi C ^a   Cullum, C Munro ^a,b   Hynan, Linda S ^a,b   Lacritz, Laura H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Alzheimer's disease; Dementia; Neuropsychologic assessment; Progression

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE COURSE; DISEASE REGISTRY; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEGRO; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RACE DIFFERENCE; RATING SCALE; SCORING SYSTEM; TIME;

AGED; ALZHEIMER DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS;

EID: 77953279825     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e3181b76415     Document Type: Article

References (19)

1. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39:1159-1165.
2. Fisher NJ, Rourke BP, Bieliauskas LA. Neuropsychological subgroups of patients with Alzheimer's disease: an examination of the first 10 years of CERAD data. J Clin Exp Neuropsychol. 1999;21:488-518.
3. Morris JC, Edland S, Clark CC, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology. 1993;4:2457-2465.
4. Welsh KA, Butters N, Hughes JP, et al. Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol. 1992;49:448-452.
5. Welsh-Bohmer KA, Mohs RC. Neuropsychological assessment of Alzheimer's disease. Neurology. 1997;49:S11-S13.
6. Chandler MJ, Lacritz LH, Hynan LS, et al. A total score for the CERAD neuropsychological battery. Neurology. 2005;65:102-106.
7. Welsh KA, Butters N, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. 1994;44:609-614.
8. Fillenbaum GG, Woodbury MA. Typology of Alzheimer's disease: Findings from CERAD data. Aging Ment Health. 1998;2:105-127.
9. McKhann G, Drachmann D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
10. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59:12-19.
11. Hermann BP, Seidenburg M, Schoenfeld J, et al. Empirical techniques for determining the reliability, magnitude, and pattern of neuropsychological change after epilepsy surgery. Epilepsia. 1996;37:942-950.
12. Storandt M, Grant EA, Miller JP, et al. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology. 59:1034-1041.
13. Berg L. Clinical Dementia Rating (CDR). Psychopharmacol Bull. 2002;24:637-639.
14. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects. Br J Psychiatry. 1968;114:797-811.
15. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
16. Van Belle G, Uhlmann RF, Hughes JP. Reliability of estimates of changes in mental status test performance in senile dementia of the Alzheimer type. J Clin Epidemiol. 1990;43:589-595.
17. Clark CM, Sheppard L, Fillenbaum GG, et al. Variability in annual Mini-Mental State Examination Score in patients with probable Alzheimer's disease. Arch Neurol. 1999;56:857-862.
18. Holmes C, Lovestone S. Long-term cognitive and functional decline in late onset Alzheimer's disease: therapeutic implications. Age Ageing. 2003;32:200-204.
19. Chelune GJ, Naugle RI, Luders H, et al. Individual change after epilepsy surgery: practice effects and base-rate information. Neuropsychology. 1993;7:41-52.